Long-term effects on serotonin transporter mRNA expression of chronic neonatal exposure to a serotonin reuptake inhibitor.

作者: Henrik H Hansen , Jens D Mikkelsen

DOI: 10.1016/S0014-2999(98)00349-5

关键词:

摘要: Chronic administration of clomipramine or other serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibitors to neonatal rats produces behaviours that resemble a depressive state in the adult animal, and this model is therefore regarded as putative animal depression. Alterations activity central 5-HT system are important understanding pathophysiology depression, therefore, we examined whether was associated with changes expression 5-HT1A receptor, 5-HT1B transporter mRNA dorsal raphe nucleus hippocampus. Wistar were injected twice daily 5-chloro-1-[3-(dimethylamino)propyl]-1-(4-fluoro-phenyl)-1,3-dihydroi so-benzofurane, hydrochloride (code Lu 10-134-C) at doses 15 mg kg(-1) vehicle i.p. from postnatal day 8 for 14 days. Groups (n = 10) either killed after last injection left undisturbed 69 days before they killed. The transporter, receptor CA1 hippocampus by means quantitative situ hybridisation histochemistry. Both compounds resulted an increase (40% more than vehicle) (postnatal 22). A small but significant seen clomipramine, not 10-134-C, probably reflecting clomipramine's affinity both noradrenaline transporters well number monoamine sites. Levels unchanged. In contrast, significantly decreased treatment two drugs compared vehicle. No observed any regions these animals. results show persistent behaviour previously shown also mRNA. This long-term alteration gene may result disturbances neurotransmission brain

参考文章(52)
M. J. Arranz, K. P. Lesch, D. A. Collier, E. Smeraldi, D. Bengel, C. R. Muller, R. M. Murray, George Kirov, D. Di Bella, T. Li, G. W. Roberts, A. Heils, P. Sham, G. Stober, H. P. Vallada, M. Catalano, A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders Molecular Psychiatry. ,vol. 1, pp. 453- 460 ,(1996)
M. Foguet, J.A. Hartikka, K. Schmuck, H. Lübbert, Long-term regulation of serotonergic activity in the rat brain via activation of protein kinase A. The EMBO Journal. ,vol. 12, pp. 903- 910 ,(1993) , 10.1002/J.1460-2075.1993.TB05731.X
P R Albert, Q Y Zhou, H H Van Tol, J R Bunzow, O Civelli, Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. Journal of Biological Chemistry. ,vol. 265, pp. 5825- 5832 ,(1990) , 10.1016/S0021-9258(19)39437-2
Dennis L. Murphy, Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems. Neuropsychopharmacology. ,vol. 3, pp. 457- 471 ,(1990)
N Ivgy-May, H Tamir, MD Gershon, Synaptic properties of serotonergic growth cones in developing rat brain The Journal of Neuroscience. ,vol. 14, pp. 1011- 1029 ,(1994) , 10.1523/JNEUROSCI.14-03-01011.1994
B. L. Jacobs, E. C. Azmitia, Structure and function of the brain serotonin system Physiological Reviews. ,vol. 72, pp. 165- 229 ,(1992) , 10.1152/PHYSREV.1992.72.1.165
J M Lakoski, G K Aghajanian, Effects of histamine, H1- and H2-receptor antagonists on the activity of serotonergic neurons in the dorsal raphe nucleus. Journal of Pharmacology and Experimental Therapeutics. ,vol. 227, pp. 517- 523 ,(1983)
R D Blakely, H C Hartzell, L J De Felice, MOLECULAR PHYSIOLOGY OF NOREPINEPHRINE AND SEROTONIN TRANSPORTERS The Journal of Experimental Biology. ,vol. 196, pp. 263- 281 ,(1994) , 10.1242/JEB.196.1.263